Back to Journals » Drug Design, Development and Therapy » Volume 16
Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial [Corrigendum]
Deng Y, Qin Z, Wu Q, et al. Drug Des Devel Ther. 2022;16:2439‒2451.
The authors have informed the journal that Remimazolam Tosilate was used in this study, not Remimazolam Besylate as indicated throughout the paper.
The authors apologize for any confusion this may have caused.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.